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ELISA enzyme-linked immunosorbent assay 
CA cancer antigen  
CEA carcinoembryonic antigen 
QDs quantum dots  
 
In this study, we have designed a similar highly sensitive and specific diagnostic system based on QD-encoded microbeads to 
detect specific markers of female reproductive system tumors. Preparation of optically encoded fluorescent microbeads of 
different sizes intended for immunodiagnostics is based on layer-by-layer electrostatic deposition of charged polymers onto the 
charged surface of polystyrene latex beads. Water-soluble CdSe/ZnS QDs emitting in the orange region (585 nm) were deposited 
between polymer layers to form an individual optical code (Brazhnik et al. (2014); Brazhnik et al. (2015)). This technology 
makes it possible to obtain an almost unlimited number of individual identification codes for biomolecule tagging by using 
multiple QD color combinations and different sizes of encoded microparticles. 
We prepared sets of QD-encoded microbeads of different sizes and bound capture antibodies (Abs) against different cancer 
biomarkers (CA 15-3, carcinoembryonic antigen (CEA), and CA 125) to their surfaces. These cancer-specific biomarkers are 
generally found in serum of women with reproductive system disorders, in particular, breast cancer. The capture monoclonal Abs 
were chemically linked to the bead polymer shell. These antigen-specific microbeads have been calibrated with the calibrator 
standards and used to test serum samples from cancer patients in comparison to healthy donors. A set of serum samples from 
patients with different stages of breast cancer and from healthy donors were collected for quantitative analysis of target 
biomarkers. The collected data were compared with the results of the “gold standard” enzyme-linked immunosorbent assay 
(ELISA). 
The results obtained pave the way to the development of multiplexed arrays based on QD-encoded beads as an advanced 
alternative to the conventional techniques of cancer marker detection, especially for early diagnosis. 
2. Experimental part 
2.1. Preparation of suspension array based on QD-encoded beads 
CdSe/ZnS semiconductor fluorescent nanoparticles or QDs emitting at 585 nm were synthesized from organometallic 
compounds by colloidal chemistry methods (Sukhanova, Even-Desrumeaux et al. (2012); Stsiapura et al. (2006)) their surface 
properties were analyzed using Fourier Transform Infrared Spectrophotometer (FTIR-8400S, Shimadzu); QDs were kindly 
provided by Dr. Pavel Samokhvalov (Laboratory of Nano-Bioengineering, Moscow Engineering Physics Institute, Moscow, 
Russia). The QDs were solubilized with derivatives of polyethylene glycol containing both thiol and carboxyl groups (Thermo 
Fisher Scientific, Moscow, Russia) as described previously (Brazhnik et al. (2015); Sukhanova et al. (2004)). 
Carboxylated melamine resin microparticles of different diameters (4.08, 6.1, and 8.24 μm) were purchased from 
Microparticles GmbH (Berlin, Germany) and used as matrix cores for the preparation of QD-encoded microbeads. Differently 
charged organic polyelectrolytes, namely, poly(allylamine hydrochloride), poly(sodium 4-styrenesulfonate) and sodium salt of 
poly(acrylic acid) (Sigma-Aldrich, Moscow, Russia) were used to form multilayer shells on the surface of the carboxylated 
particles (Susha et al. (2000)). Water-soluble CdSe/ZnS QDs emitting at 585 nm were attached to the pre-surface layers of 
monodispersed polymer-coated melamine resin microbeads with different diameters using the procedure of layer-by-layer 
assembly as described previously [Brazhnik et al. (2015)]. 
Monoclonal capture Abs, detection Abs (different for different antigens), and standard ELISA kits for three markers of female 
reproductive system tumors (CA 15-3, CEA, CA 125) were purchased from Fujirebio Diagnostics, Inc (Göteborg, Sweden). 
Capture monoclonal antibodies were conjugated to the surface of QD-encoded microbeads through carbodiimide crosslinkers 
(Thermo Fisher Scientific, Moscow, Russia). Detection Abs were biotinylated with the Sulfo-NHS-LC-biotin reagent (Thermo 
Fisher Scientific, Moscow, Russia) according to the manufacturer's protocol. The secondary fluorescent label, streptavidin-Tri-
COLOR, was purchased from Sigma-Aldrich (Moscow, Russia). Serum samples from patients with breast cancer and healthy 
donors were provided by Blokhin Cancer Research Center of the Russian Academy of Medical Sciences (Moscow, Russia). 
2.2. Immunodiagnostic analysis with the use of the array for cancer marker profiling based on QD-encoded beads 
To perform immunodiagnostic suspension analysis, we employed the “lab-on-a-bead” detection principle (Brazhnik et al. 
(2015)). According to it, monoclonal capture Abs against each target antigen (CA 15-3, CEA, and CA 125) were chemically 
linked to the surface of the respective population of QD-encoded beads (Table 1). 
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Capture Abs were conjugated with the microbead polymer shell using carbodiimide chemistry according to the manufacturer's 
protocol. The beads were then incubated with blocking solutions (containing bovine serum albumin and casein) to prevent 
nonspecific binding and false-positive results. 
Table 1. Individual QD-encoded bead populations and specific antibodies adapted for simultaneous detection of markers of female reproductive 
system tumors. 




4.08 μm/QD 585 nm ɋȺ 15-3 Ma695 Ma552 
6.1 μm/QD 585 nm ɋEA 12-140-10 12-140-1 
8.24 μm/QD 585 nm ɋȺ 125 Ov197 Ov185 
 
To balance/equilibrate the effective working surface of the antigen-specific populations of beads of different diameters, the 
total effective amount of 6.1- and 8.24-μm microbeads was calculated as follows: 
S
sN μm) (4.08 50000u .  (1) 
Here, N is the amount of 6.1- and 8.24-μm microbeads for each analysis, S is the surface area of the 6.1- and 8.24-μm 
microbeads, and s (4.08 μm) is the surface area of the 4.08-μm microbeads. 
The antigen-specific fluorescent microbeads were calibrated using the corresponding commercial standards (Fujirebio 
Diagnostics). For each analysis, 50 000 beads with the diameter of 4.08 μm and the corresponding calculated amounts of 6.1- 
and 8.24-μm microbeads were used. For clinical tests, a mixture of the three antigen-specific microbead populations was 
sequentially incubated with all components of the immunodiagnostic complex. The resultant complete surface immune 
complexes consisted of capture monoclonal Abs, the target analyte (cancer antigen), biotinylated detection monoclonal Abs, and 
the streptavidin-linked fluorophore (streptavidin-Tri-COLOR). The microarrays based on QD-encoded microbeads were 
processed and analyzed using classical flow cytometry (FACSCanto II, Becton Dickinson, USA). 
Serum samples from patients with different stages of breast cancer and samples from healthy donors were collected for 
quantitative analysis of cancer serum antigens. All the samples were analyzed using the “gold standard” ELISA test to determine 
the exact concentration according to the standard clinical diagnostic requirements. Several cancer-positive serum samples have 
been analyzed using the designed multiplexed suspension array in comparison with serum of healthy donors serving as a control. 
3. Results and discussion 
3.1. Characteristics of the suspension array based on QD-encoded beads 
The adapted procedure of charged polymer deposition onto the surface of beads and incorporation of water-soluble 
carboxylated QDs was shown to be suitable for preparing optically encoded microparticles and using them in immunodiagnostic 
suspension arrays (Sukhanova et al. (2007); Brazhnik et al. (2014); Brazhnik et al. (2015)). The resultant single-color QD-
encoded microbeads exhibited intense fluorescence with emission wavelengths that were nearly identical to those of the original 
QDs (data not shown). Flow cytometry analysis demonstrated that individual microbead populations (4.08 μm/QDs 585 nm, 6.1 
μm/QDs 585 nm, and 8.24 μm/QDs 585 nm) were extremely bright and homogenous and were clearly distinguishable in the 
mixture by size and optical code (see Fig. 1). 
  



























ps on the sur





























sts with the 







 analysis of the m





n array, we 
ical sample,
 results of ca

















t the cancer 
m, 6.1 μm/Q

















 SSC-A) and (b)
de (QD 585 nm 
 based on QD
markers CA 








ur data (data n
















ates of the b
ere used to 











/QDs 585 nm, 6.
-A) distributions
ds 
and CA 125 















.1 μm/QDs 585 n




























rs. The data 
 detection wit
el, 670 nm) 
compared wit













































ig. 2. Flow cytom
ductive system t
ferent stages of b















 this study, w
imultaneous 
rent sizes em
. We used an






























s and used 










 growth, in 
























 bead optical cod
cence of the strep




















ng with the r
re applicable
ts. 
s used for simult
s detection of thr
g different levels





uvada et al. (
in the most w
d parameters
 by the prope













esults of the “
 to efficient a
aneous detection
ee cancer marker









rties of a fixe
que optical an
to fit the anal
(Nolan et al. 
, viruses, anti










 of CA 15-3, CE
s in three individ
























A, and CA 125, m
ual serum sampl
lyzed serum sam
nt of the cancer 
n cancer-spe
arkers is es





 to label diff
ofiles and are


























































240   Kristina Brazhnik et al. /  Physics Procedia  73 ( 2015 )  235 – 240 
Our results offer new prospects for high-throughput screening that could make use of the unique and robust fluorescence 
properties of QD-encoded beads. The new generation of bead-based assays can ensure efficient simultaneous determination of 
multiple antigens and enhance the clinical sensitivity and specificity of cancer marker screening in multiplexed diagnostics. 
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